Pre-Test Tackling Myths about Long-Acting Injectables in Schizophrenia: LAIs are a Last Resort for Patients (Module 2) Pre-Test In 2021, the American Psychiatric Association supported which of the following statements regarding the use of long-acting injectable (LAI) antipsychotic treatments? LAIs should be recommended based on preference or a history of uncertain adherence Oral anti-psychotics must be used in all patients before LAIs to identify efficacy Patient goals and tobacco use should be considered when recommending LAIs Psychosocial intervention requirements are mitigated by use of LAIs Unsure Please now rate your ability to use currently available therapies to manage schizophrenia. Excellent Very Good Good Fair Poor
